Skip to main content
. Author manuscript; available in PMC: 2013 Jan 6.
Published in final edited form as: Brain Res. 2011 Oct 20;1429:52–60. doi: 10.1016/j.brainres.2011.10.025

Figure 3.

Figure 3

Effects of neonatal citalopram dose on mounting behavior. The effects of SAL (n = 16), CTM5 (n = 16), CTM10 (n = 15) and CTM20 (n = 11) on (a.) the percentage of rats displaying mounting behavior. Kaplan-Meier survival analysis of mounting behavior using Log-Rank (Mantel-Cox) statistic showed an overall impairment in mounting (Log-Rank = 12.94, df = 3, P = 0.0048) with a significant reduction in each treatment group compared to SAL group (SAL vs. CTM5 = 5.442, df=1, P = 0.0197; SAL vs. CTM10 = 8.782, df=1, P = 0.0030; SAL vs. CTM20 = 8.580, df=1, P = 0.0034) (b) the number of mounts. Data represents the mean ± SEM. Single-factor ANOVA followed by Bonferroni corrected t-test and Post-test for linear trend (* P < 0.05). A significant dose-dependent trend for a reduction in mount number was found.